Spirendolol

Spirendolol
Nazivi
	IUPAC naziv 4-[3-(tert-Butilamino)-2-hidroksipropoksi]spiro[3H-inden-2,1'-cikloheksan]-1-on
Identifikacija
CAS broj	65429-87-0 ;
3D model (Jmol)	interaktivna slika;
ChemSpider	62090;
PubChem C ID	68857;
UNII	96789094BR ;
	SMILES CC(C)(C)NCC(COC1=CC=CC2=C1CC3(C2=O)CCCCC3)O; ; ; ; ; ;
Svojstva
Hemijska formula	C21H31NO3
Molarna masa	345,48 g·mol−1
	Ukoliko nije drugačije napomenuto, podaci se odnose na standardno stanje materijala (na 25 °C [77 °F], 100 kPa).
	Reference infokutije

Spirendolol je antagonist beta adrenergičkog receptora.^[3]

Reference[уреди | уреди извор]

^ Li Q, Cheng T, Wang Y, Bryant SH (2010). „PubChem as a public resource for drug discovery.”. Drug Discov Today. 15 (23-24): 1052—7. PMID 20970519. doi:10.1016/j.drudis.2010.10.003. уреди
^ Evan E. Bolton; Yanli Wang; Paul A. Thiessen; Stephen H. Bryant (2008). „Chapter 12 PubChem: Integrated Platform of Small Molecules and Biological Activities”. Annual Reports in Computational Chemistry. 4: 217—241. doi:10.1016/S1574-1400(08)00012-1.
^ Mostaghim, R; Maddox, YT; Ramwell, PW (1986). „Endothelial potentiation of relaxation response to beta adrenoceptor blocking agents”. The Journal of Pharmacology and Experimental Therapeutics. 239 (3): 797—801. PMID 2879033.